Stada explores €6bn acquisition of CVC-backed Cooper Consumer Health

Stada is reportedly eyeing a major move by looking into acquiring Cooper Consumer Health, a company backed by CVC Capital, in a deal that could be worth approximately €6 billion. This potential acquisition could significantly bolster Stada's position in the consumer health market, bringing in a range of popular over-the-counter products. The implications extend beyond the immediate financial gains, as such a merger could reshape the competitive landscape in the pharmaceutical industry, affecting market dynamics and consumer health product availability.